Sathyen A. Prabhu

Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas

Jennifer Kimberly Lue, Sathyen A. Prabhu, Yuxuan Liu et al. · Clinical Cancer Research · 2019 · 75 citations · Full text

Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression

Arif Hussain, Geetganga Harish, Sathyen A. Prabhu et al. · Cancer Epidemiology · 2012 · 63 citations

Matrix Metalloproteinase-1 Expression, Cervical Cancer, Chemoprevention Strategy +9

Sulforaphane Inhibits Growth of Human Breast Cancer Cells and Augments the Therapeutic Index of the Chemotherapeutic Drug, Gemcitabine

Arif Hussain, Javeria Mohsin, Sathyen A. Prabhu et al. · Asian Pacific Journal of Cancer Prevention · 2013 · 53 citations · Full text

Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib

Jennifer E. Amengual, Sathyen A. Prabhu, Maximilian Lombardo et al. · Clinical Cancer Research · 2016 · 28 citations · Full text

Drug Target, Acquired Drug Resistance, Immunology +19

MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression

William Yang, Elie Khoury, Qianyu Guo et al. · Oncogene · 2020 · 23 citations

Signal Transduction, Signaling Pathway, Medicine +11